HIGHLIGHTS
- who: Hancong Sun et al. from the Institute of Biotechnology, Academy of Military Medical Sciences, Beijing, China have published the article: Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants, in the Journal: Viruses 2022, 14, x FOR PEER REVIEW of /2022/
- what: The neutralizing capacity of convalescent plasma from COVID-19 convalescent patients in Wuhan was tested these pseudoviruses revealing the immune evasion of the work established a practical for SARS-CoV-2 variants which can be conducted safely under biosafety level-2 (BSL-2) conditions and this will be a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.